Concepedia

Shuya Takahashi

ST

4

Publications

115

Citations

4

H-Index

1993

Active since

Affiliations

Taisho Pharmaceutical (Japan)(Current)

Nissan Chemical Corporation (Japan)

Shuya Takahashi is an author at Taisho Pharmaceutical (Japan) specializing in medicine, fibrosis, and molecular physiology.

Top concepts

MedicineHealthFibrosisGynecologyImmunologyPhysiologyKinesiologyCell BiologyInflammationPharmacology

Publications per year

1993–2009

4

Publications

4

Cyclooxygenase inhibitors augment the production of pro‐matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes

Akira Ito, Takashi Nose, Shuya Takahashi et al. · FEBS Letters · 1995 · 55 citations · Full text

Involvement of protein kinase C in the interleukin 1α-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts

Shuya Takahashi, Takashi Sato, Akira Itô et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1993 · 34 citations

Inflammation, Cytokine, Fibrosis +13

NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model

Norihisa Ishiwata, Kazuo Noguchi, Masafumi Kawanishi et al. · Life Sciences · 2007 · 16 citations

Molecular Pharmacology, Kinesiology, Molecular Physiology +8

NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects

Miyuki Hori, Takehisa Iwama, Yumiko Asakura et al. · European Journal of Pharmacology · 2009 · 10 citations

Rows per page

1–4 of 4